Compile Data Set for Download or QSAR
Report error Found 60 Enz. Inhib. hit(s) with all data for entry = 13065
TargetTyrosine-protein kinase JAK2(Human)
Oscotec

US Patent
LigandPNGBDBM756224(WO2011053861, Compound 136)
Affinity DataIC50: 5.5nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Oscotec

US Patent
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 5.5nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 5.5nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756196(US12350272, Compound 226)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756195(US12350272, Compound 225)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM50422751(Denfivontinib | G-749 | DENFIVONTINIB | US12350272...)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756206(US12350272, Compound 236)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756202(US12350272, Compound 232)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756201(US12350272, Compound 231)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756200(US12350272, Compound 230)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756211(US12350272, Compound 241)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756210(US12350272, Compound 240)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM50422751(Denfivontinib | G-749 | DENFIVONTINIB | US12350272...)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756208(US12350272, Compound 238)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Oscotec

US Patent
LigandPNGBDBM756223(US2010/054853, Compound 8 | (5 -2-(pyrrolidin-3 -y...)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756223(US2010/054853, Compound 8 | (5 -2-(pyrrolidin-3 -y...)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756195(US12350272, Compound 225)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM50172079(CHEMBL3809489 | US20250026773, Positive Drug 1 BGB...)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756225(WO2011053861, Compound 203)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756224(WO2011053861, Compound 136)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756196(US12350272, Compound 226)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756214(US12350272, Compound 244)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756213(US12350272, Compound 243)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756212(US12350272, Compound 242)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756211(US12350272, Compound 241)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756210(US12350272, Compound 240)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756209(US12350272, Compound 239)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756208(US12350272, Compound 238)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Oscotec

US Patent
LigandPNGBDBM144333(US8969336, 577 | US12350272, Compound ASP2215)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPDBSimilars
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM144333(US8969336, 577 | US12350272, Compound ASP2215)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPDBSimilars
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756219(US12350272, Compound 249)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756218(US12350272, Compound 248)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756217(US12350272, Compound 247)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756216(US12350272, Compound 246)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756215(US12350272, Compound 245)
Affinity DataIC50: 55nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756198(US12350272, Compound 228)
Affinity DataIC50: 550nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756197(US12350272, Compound 227)
Affinity DataIC50: 550nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756194(US12350272, Compound 224)
Affinity DataIC50: 550nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Oscotec

US Patent
LigandPNGBDBM50172079(CHEMBL3809489 | US20250026773, Positive Drug 1 BGB...)
Affinity DataIC50: 550nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756193(US12350272, Compound 223)
Affinity DataIC50: 550nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Oscotec

US Patent
LigandPNGBDBM756193(US12350272, Compound 223)
Affinity DataIC50: 550nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756191(US12350272, Compound 221)
Affinity DataIC50: 550nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756193(US12350272, Compound 223)
Affinity DataIC50: 550nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Oscotec

US Patent
LigandPNGBDBM756225(WO2011053861, Compound 203)
Affinity DataIC50: 550nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756205(US12350272, Compound 235)
Affinity DataIC50: 550nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756204(US12350272, Compound 234)
Affinity DataIC50: 550nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Oscotec

US Patent
LigandPNGBDBM756198(US12350272, Compound 228)
Affinity DataIC50: 550nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756203(US12350272, Compound 233)
Affinity DataIC50: 550nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Oscotec

US Patent
LigandPNGBDBM756198(US12350272, Compound 228)
Affinity DataIC50: 550nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Oscotec

US Patent
LigandPNGBDBM756196(US12350272, Compound 226)
Affinity DataIC50: 550nMAssay Description:Compounds of Formula (I) as obtained above were initially diluted to 10 nM in 100% DMSO (CALBIOCHEM™) for storage and made into kinase buffer solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

Displayed 1 to 50 (of 60 total ) | Next | Last >>
Jump to: